These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19027875)

  • 21. Perineural injection of etanercept as a treatment for postamputation pain.
    Dahl E; Cohen SP
    Clin J Pain; 2008 Feb; 24(2):172-5. PubMed ID: 18209523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of chronic atopic dermatitis treated with soluble tumor necrosis factor receptor therapy.
    Rullan P; Murase J
    J Drugs Dermatol; 2009 Sep; 8(9):873-6. PubMed ID: 19746681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
    Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro.
    Grattendick KJ; Nakashima JM; Feng L; Giri SN; Margolin SB
    Int Immunopharmacol; 2008 May; 8(5):679-87. PubMed ID: 18387510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
    Tobinick E
    Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports.
    Tobinick EL
    Clin Ther; 2003 Aug; 25(8):2279-88. PubMed ID: 14512134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice.
    Nemoto H; Konno S; Sugimoto H; Nakazora H; Nomoto N; Murata M; Kitazono H; Fujioka T
    Exp Mol Pathol; 2011 Jun; 90(3):264-70. PubMed ID: 21324312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats.
    Bayramgürler D; Karson A; Ozer C; Utkan T
    Physiol Behav; 2013 Jul; 119():145-8. PubMed ID: 23769689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury.
    Guthmann F; Wissel H; Rüstow B
    Exp Lung Res; 2009 Nov; 35(9):770-80. PubMed ID: 19916860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury.
    Wolthuis EK; Vlaar AP; Choi G; Roelofs JJ; Haitsma JJ; van der Poll T; Juffermans NP; Zweers MM; Schultz MJ
    Shock; 2009 Mar; 31(3):262-6. PubMed ID: 18650784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.
    Bodar EJ; van der Hilst JC; Drenth JP; van der Meer JW; Simon A
    Neth J Med; 2005; 63(7):260-4. PubMed ID: 16093577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidural etanercept for lumbar radiculopathy.
    Malik K
    Anaesth Intensive Care; 2007 Apr; 35(2):301-2. PubMed ID: 17444328
    [No Abstract]   [Full Text] [Related]  

  • 35. Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition.
    Wachter T; Murach WM; Bröcker EB; Schön MP
    Br J Dermatol; 2007 Sep; 157(3):627-9. PubMed ID: 17596151
    [No Abstract]   [Full Text] [Related]  

  • 36. The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists.
    Wildemann B; Rudofsky G; Kress B; Jarius S; Konig F; Schwenger V
    Neurology; 2007 May; 68(20):1742-4. PubMed ID: 17360963
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
    Page SJ
    CNS Drugs; 2013 May; 27(5):395-7. PubMed ID: 23580176
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted etanercept for discogenic neck pain: uncontrolled, open-label results in two adults.
    Tobinick EL
    Clin Ther; 2003 Apr; 25(4):1211-8. PubMed ID: 12809967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
    Butchart J; Brook L; Hopkins V; Teeling J; Püntener U; Culliford D; Sharples R; Sharif S; McFarlane B; Raybould R; Thomas R; Passmore P; Perry VH; Holmes C
    Neurology; 2015 May; 84(21):2161-8. PubMed ID: 25934853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of resistant giant cell arteritis with etanercept.
    Docken WP
    Ann Rheum Dis; 2004 Apr; 63(4):469; author reply 469-70. PubMed ID: 15020354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.